Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.69T
24h Vol:
$10.68B
Dominance:
MSFT:4.75%
Stocklytics Platform
Asset logo  MYO
Myomo
MYO
73 / 100
Penny Stock
$3.64arrow_drop_down1.08%-$0.04

Performance History

Stocklytics logo
Key Stats
Open$3.71
Prev. Close$3.68
EPS-0.28
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap104885144.00
PE Ratio-
LOWHIGH
Day Range3.57
3.76
52 Week Range0.37
5.58
Ratios
P/B Ratio9.41
Revenue$19.24M
Operating M. %-51.16%
Earnings$0.00
Earnings Growth %24.00%
EBITDA Margin %-41.93%
ROE %-106.17%
EPS-0.28

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$770.00
24H (%)arrow_drop_down0.14%
24H ($)-$1.12
MARKET CAP$731.81B
PRICE$524.63
24H (%)arrow_drop_up0.64%
24H ($)$3.35
MARKET CAP$482.86B
PRICE$154.64
24H (%)arrow_drop_up0.23%
24H ($)$0.36
MARKET CAP$372.16B
PRICE$131.19
24H (%)arrow_drop_up0.23%
24H ($)$0.31
MARKET CAP$332.27B

About Myomo (MYO)

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Paul R. Gudonis
Headquarters
Boston
Employees
100
Exchange
NYSE
add Myomo  to watchlist

Keep an eye on Myomo

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Myomo 's (MYO) price per share?

The current price per share for Myomo (MYO) is $3.64. The stock has seen a price change of -$0.04 recently, indicating a -1.09% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Myomo (MYO)?

For Myomo (MYO), the 52-week high is $5.58, which is 53.3% from the current price. The 52-week low is $0.37, the current price is 881.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Myomo (MYO) a growth stock?

Myomo (MYO) has shown an average price growth of 0.41% over the past three years. It has received a score of 95 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Myomo as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Myomo (MYO) stock price performance year to date (YTD)?

As of the latest data, Myomo (MYO) has a year-to-date price change of -24.01%. Over the past month, the stock has experienced a price change of 14.11%. Over the last three months, the change has been 22.15%. Over the past six months, the figure is 18.95%. Looking at a longer horizon, the five-year price change stands at -87.49%.

help
Is Myomo (MYO) a profitable company?

Myomo (MYO) has a net income of -$8.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.51% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -51.16% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $19.24M, with a revenue growth rate of 23.7%, providing insight into the company's sales performance and growth. The gross profit is $13.18M. Operating income is noted at -$8.23M. Furthermore, the EBITDA is -$8.07M.

help
What is the market capitalization of Myomo (MYO)?

Myomo (MYO) has a market capitalization of $104.89M. The average daily trading volume is 310.39K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level